Your browser doesn't support javascript.
loading
The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer.
Topcu, Turkan Ozturk; Ozdemir, Feyyaz; Kavgaci, Halil; Gunaldi, Meral; Kocoglu, Hakan; Imamoglu, Goksen Inanc; Mentese, Ahmet; Yaman, Serap Ozer; Orem, Asim; Aydin, Fazil.
Afiliación
  • Topcu TO; Department of Medical Oncology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Ozdemir F; Department of Medical Oncology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Kavgaci H; Department of Medical Oncology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Gunaldi M; Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
  • Kocoglu H; Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
  • Imamoglu GI; Department of Medical Oncology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
  • Mentese A; Department of Biochemistry, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Yaman SO; Department of Biochemistry, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Orem A; Department of Biochemistry, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
  • Aydin F; Department of Medical Oncology, School of Medicine, Karadeniz Technical University, Trabzon, Turkey.
J Cancer Res Ther ; 14(3): 608-613, 2018.
Article en En | MEDLINE | ID: mdl-29893327
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptores del Activador de Plasminógeno Tipo Uroquinasa / Anhidrasa Carbónica IX / Antígenos de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: India
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptores del Activador de Plasminógeno Tipo Uroquinasa / Anhidrasa Carbónica IX / Antígenos de Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Cancer Res Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: India